Treballs finals del Màster de Fonaments de Ciència de Dades, Facultat de matemàtiques, Universitat de Barcelona, Any: 2018, Tutor: Vicent Ribas Ripoll[en] Introduction: Shock is a life-threatening condition affecting about one third of patients in the ICU. The most common types of Shock are Septic and Cardiogenic, affecting 62% and 16% of Shock patients, respectively. A rapid and specialized treatment focused on the type of Shock is crucial for reducing its high mortality rate. Unfortunately, current therapies strive to reduce the medical signs present by the patients rather than target the cause of Shock. A better understanding of the mechanisms and pathophysiology of Shock is mandatory for improving its diagnosis. Omic data and Machine ...
Trauma with hypovolemic shock is an extreme pathological state that challenges the body to maintain ...
During the last years, proteomic studies have revealed several interesting findings in experimental ...
In this work, we examined plasma metabolome, proteome and clinical features in patients with severe ...
This work attempts to identify biomarkers that can be used as indicators for mortality prediction in...
Background: The ShockOmics study (ClinicalTrials.gov identifier NCT02141607) is a multicenter prospe...
The main objective of this thesis is to analyse peptidomics data and evaluate its use in the mortali...
Background: The ShockOmics study (ClinicalTrials.gov identifier NCT02141607) is a multicenter prospe...
BackgroundThe ShockOmics study (ClinicalTrials.gov identifier NCT02141607) is a multicenter prospect...
Background: The ShockOmics study (ClinicalTrials.gov identifier NCT02141607) is a multicenter prospe...
Circulatory shock is a life-threatening disease that accounts for around one-third of all admissions...
Sepsis is an organ dysfunction life-threatening disease that is caused by a dysregulated body respon...
Currently, there is no therapy targeting septic cardiomyopathy (SC), a key contributor to organ dysf...
Background: Uncontrolled proteolysis contributes to cell injury and organ dysfunction in animal mode...
Currently, there is no therapy targeting septic cardiomyopathy (SC), a key contributor to organ dysf...
Trauma with hypovolemic shock is an extreme pathological state that challenges the body to maintain ...
During the last years, proteomic studies have revealed several interesting findings in experimental ...
In this work, we examined plasma metabolome, proteome and clinical features in patients with severe ...
This work attempts to identify biomarkers that can be used as indicators for mortality prediction in...
Background: The ShockOmics study (ClinicalTrials.gov identifier NCT02141607) is a multicenter prospe...
The main objective of this thesis is to analyse peptidomics data and evaluate its use in the mortali...
Background: The ShockOmics study (ClinicalTrials.gov identifier NCT02141607) is a multicenter prospe...
BackgroundThe ShockOmics study (ClinicalTrials.gov identifier NCT02141607) is a multicenter prospect...
Background: The ShockOmics study (ClinicalTrials.gov identifier NCT02141607) is a multicenter prospe...
Circulatory shock is a life-threatening disease that accounts for around one-third of all admissions...
Sepsis is an organ dysfunction life-threatening disease that is caused by a dysregulated body respon...
Currently, there is no therapy targeting septic cardiomyopathy (SC), a key contributor to organ dysf...
Background: Uncontrolled proteolysis contributes to cell injury and organ dysfunction in animal mode...
Currently, there is no therapy targeting septic cardiomyopathy (SC), a key contributor to organ dysf...
Trauma with hypovolemic shock is an extreme pathological state that challenges the body to maintain ...
During the last years, proteomic studies have revealed several interesting findings in experimental ...
In this work, we examined plasma metabolome, proteome and clinical features in patients with severe ...